ExoDx Prostate(IntelliScore)
GPTKB entity
Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
diagnosis
|
| gptkbp:alternativeTo |
prostate biopsy
|
| gptkbp:analyzes |
urine exosomal RNA
|
| gptkbp:biomarkers |
gptkb:ERG
SPDEF PCA3 |
| gptkbp:clinical_utility |
reduce unnecessary biopsies
|
| gptkbp:FDA_status |
FDA cleared
|
| https://www.w3.org/2000/01/rdf-schema#label |
ExoDx Prostate(IntelliScore)
|
| gptkbp:launched |
2017
|
| gptkbp:location_available |
gptkb:United_States
|
| gptkbp:manufacturer |
gptkb:Exosome_Diagnostics
|
| gptkbp:noninvasive |
true
|
| gptkbp:purpose |
aid in decision to perform initial prostate biopsy
|
| gptkbp:result_type |
risk score
|
| gptkbp:targetAudience |
men 50 years or older
men with PSA 2-10 ng/mL |
| gptkbp:type |
urine
|
| gptkbp:usedFor |
prostate cancer risk assessment
|
| gptkbp:bfsParent |
gptkb:Exosome_Diagnostics
|
| gptkbp:bfsLayer |
8
|